Browsing: Elucid

What You Should Know Cardiovascular imaging AI innovator Elucid has received U.S. FDA 510(k) clearance (K262015, authorized September 29, 2026)…

Dive Brief: Elucid has raised $55 million to commercialize its cardiovascular imaging platform and expand partnerships with medtech companies.  The…

What You Should Know Boston-based cardiovascular medtech innovator Elucid closed an oversubscribed $55M Series D financing round, bringing its cumulative…

Leaders in clinical, product innovation, and market access will provide guidance for PlaqueIQTM strategy BOSTON & SCCT ANNUAL MEETING, MONTREAL–(BUSINESS…

 Dr. Robert Pelberg, SVP of Medical Afffairs at Elucid What You Should Know:  – Elucid, an AI medical technology company…